← Back to directory

Robert J. Kurman

Researcher Next ID · RN-024406

Researcher · Medicine

Johns Hopkins University

Baltimore, Taiwan

Not currently recruitingFunding unknown
Works count
488
Citation count
57,786
H-index
135
i10-index
343

Research interests

Medicine
Immunology and Microbiology
Ovarian cancer diagnosis and treatment
Endometrial and Cervical Cancer Treatments
Cervical Cancer and HPV Research
Reproductive System and Pregnancy
Endometriosis Research and Treatment

Publications

  • Blaustein's Pathology of the Female Genital Tract

    Journal · 2019 · https://doi.org/10.1007/978-3-319-46334-6

  • WHO classification of tumours of female reproductive organs

    International Agency for Research on Cancer eBooks · 2014

  • Prevalence of the Alternative Lengthening of Telomeres Telomere Maintenance Mechanism in Human Cancer Subtypes

    American Journal Of Pathology · 2011 · https://doi.org/10.1016/j.ajpath.2011.06.018

  • Impact of Human Papillomavirus (HPV)-6/11/16/18 Vaccine on All HPV-Associated Genital Diseases in Young Women

    JNCI Journal of the National Cancer Institute · 2010 · https://doi.org/10.1093/jnci/djp534

  • The Origin and Pathogenesis of Epithelial Ovarian Cancer: A Proposed Unifying Theory

    The American Journal of Surgical Pathology · 2010 · https://doi.org/10.1097/pas.0b013e3181cf3d79

  • The Impact of Quadrivalent Human Papillomavirus (HPV; Types 6, 11, 16, and 18) L1 Virus‐Like Particle Vaccine on Infection and Disease Due to Oncogenic Nonvaccine HPV Types in Generally HPV‐Naive Women Aged 16–26 Years

    The Journal of Infectious Diseases · 2009 · https://doi.org/10.1086/597307

  • The Impact of Quadrivalent Human Papillomavirus (HPV; Types 6, 11, 16, and 18) L1 Virus‐Like Particle Vaccine on Infection and Disease Due to Oncogenic Nonvaccine HPV Types in Sexually Active Women Aged 16–26 Years

    The Journal of Infectious Diseases · 2009 · https://doi.org/10.1086/597309

  • Notch3 Gene Amplification in Ovarian Cancer

    Cancer Research · 2006 · https://doi.org/10.1158/0008-5472.can-05-3610

  • Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial

    The Lancet Oncology · 2005 · https://doi.org/10.1016/s1470-2045(05)70101-7

  • HLA-G is a potential tumor marker in malignant ascites.

    PubMed · 2003

Current projects

    No projects listed.